TJ DaRenTang plans to sell 12% of its shares in Tianjin Shike for 1.623 billion yuan to increase cash inflow
I'm PortAI, I can summarize articles.
TJ DaRenTang plans to sell its 12% stake in Tianjin Shike Pharmaceutical Co., Ltd. for RMB 1.623 billion to increase cash inflow. In this transaction, TJ DaRenTang will transfer 4.6% equity to Haleon (China) for RMB 622 million and 7.4% equity to Haleon CH SARL for RMB 1.001 billion. After the transaction is completed, TJ DaRenTang will no longer hold shares in Tianjin Shike, and it is expected to impact the company's current investment income by approximately RMB 1.54 billion
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments